These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31228128)

  • 61. Pharmacological approaches to methamphetamine dependence: a focused review.
    Karila L; Weinstein A; Aubin HJ; Benyamina A; Reynaud M; Batki SL
    Br J Clin Pharmacol; 2010 Jun; 69(6):578-92. PubMed ID: 20565449
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacological Treatments for Cocaine Craving: What Is the Way Forward? A Systematic Review.
    Lassi DLS; Malbergier A; Negrão AB; Florio L; De Aquino JP; Castaldelli-Maia JM
    Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421870
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.
    Haile CN; Kosten TR; Kosten TA
    Am J Drug Alcohol Abuse; 2009; 35(3):161-77. PubMed ID: 19462300
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacotherapy of methamphetamine addiction: an update.
    Elkashef A; Vocci F; Hanson G; White J; Wickes W; Tiihonen J
    Subst Abus; 2008; 29(3):31-49. PubMed ID: 19042205
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A systematic review of cognitive and behavioural therapies for methamphetamine dependence.
    Lee NK; Rawson RA
    Drug Alcohol Rev; 2008 May; 27(3):309-17. PubMed ID: 18368613
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trials.
    Arkell TR; Bradshaw K; Downey LA; Hayley AC
    Addict Biol; 2022 Mar; 27(2):e13128. PubMed ID: 35229937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adding extended-release methylphenidate to psychological intervention for treatment of methamphetamine dependence: A double-blind randomized controlled trial.
    Noroozi A; Motevalian SA; Zarrindast MR; Alaghband-Rad J; Akhondzadeh S
    Med J Islam Repub Iran; 2020; 34():137. PubMed ID: 33437733
    [No Abstract]   [Full Text] [Related]  

  • 68. Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis.
    McKetin R; Leung J; Stockings E; Huo Y; Foulds J; Lappin JM; Cumming C; Arunogiri S; Young JT; Sara G; Farrell M; Degenhardt L
    EClinicalMedicine; 2019 Nov; 16():81-97. PubMed ID: 31832623
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review.
    Sharif S; Guirguis A; Fergus S; Schifano F
    Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33802176
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prescription Stimulants and the Risk of Psychosis: A Systematic Review of Observational Studies.
    Gallagher KE; Funaro MC; Woods SW
    J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):308-314. PubMed ID: 35489031
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effects of amphetamines alone and in combination with alcohol on functional neurocognition: A systematic review.
    Narayan AJ; Aitken B; Downey LA; Hayley AC
    Neurosci Biobehav Rev; 2021 Dec; 131():865-881. PubMed ID: 34626687
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Methamphetamine, amphetamine, and aggression in humans: A systematic review of drug administration studies.
    O'Malley KY; Hart CL; Casey S; Downey LA
    Neurosci Biobehav Rev; 2022 Oct; 141():104805. PubMed ID: 35926727
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Behavioral genetic contributions to the study of addiction-related amphetamine effects.
    Phillips TJ; Kamens HM; Wheeler JM
    Neurosci Biobehav Rev; 2008; 32(4):707-59. PubMed ID: 18207241
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.
    Stoops WW; Rush CR
    Expert Rev Clin Pharmacol; 2014 May; 7(3):363-74. PubMed ID: 24716825
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail.
    Hazani HM; Naina Mohamed I; Muzaimi M; Mohamed W; Yahaya MF; Teoh SL; Pakri Mohamed RM; Mohamad Isa MF; Abdulrahman SM; Ramadah R; Kamaluddin MR; Kumar J
    Front Pharmacol; 2022; 13():859563. PubMed ID: 35462918
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association Between Negative Affectivity and Craving in Substance-Related Disorders: A Systematic Review and Meta-analysis of Direct and Indirect Relationships.
    Cyr L; Bernard L; Pedinielli JL; Cutarella C; Bréjard V
    Psychol Rep; 2023 Jun; 126(3):1143-1180. PubMed ID: 35105221
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methylphenidate vs. resperidone in treatment of methamphetamine dependence: A clinical trial.
    Solhi H; Jamilian HR; Kazemifar AM; Javaheri J; Rasti Barzaki A
    Saudi Pharm J; 2014 Jul; 22(3):191-4. PubMed ID: 25061402
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Aggression and criminality in androgen abusers.
    Chegeni R; Pallesen S; Sagoe D
    Curr Opin Endocrinol Diabetes Obes; 2021 Dec; 28(6):615-624. PubMed ID: 34709216
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.